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Summary
During ubiquitin conjugation, the thioester bond that links ‘donor’ ubiquitin to ubiquitin-
conjugating enzyme (E2) undergoes nucleophilic attack by the ε-amino group of an acceptor
lysine, resulting in formation of an isopeptide bond. Models of ubiquitination have envisioned the
donor ubiquitin to be a passive participant in this process. However, we show here that the I44A
mutation in ubiquitin profoundly inhibits its ability to serve as a donor for ubiquitin chain
initiation or elongation, but can be rescued by computationally-predicted compensatory mutations
in the E2 Cdc34. The donor defect of ubiquitin-I44A can be partially suppressed either by using a
low pKa amine (hydroxylamine) as the acceptor or by performing reactions at higher pH,
suggesting that the discharge defect arises in part due to inefficient deprotonation of the acceptor
lysine. We propose that interaction between Cdc34 and the donor ubiquitin organizes the active
site to promote efficient ubiquitination of substrate.
Introduction
Attachment of ubiquitin (i.e. ubiquitination) to intracellular proteins regulates nearly all
aspects of cellular function in eukaryotes. Ubiquitination involves covalent attachment of
ubiquitin to the target protein via an isopeptide bond between the C-terminus of ubiquitin
and, most often, a lysine residue of the acceptor substrate. Additional ubiquitins can be
conjugated to any of the seven lysine residues of ubiquitin to form a polyubiquitin chain on
substrate. A chain of four or more ubiquitins linked together via lysine 48 or lysine 11
targets modified proteins for degradation by the 26S proteasome (Chau et al., 1989;
Matsumoto et al., 2010; Song and Rape, 2010; Thrower et al., 2000), whereas chains of
ubiquitin linked via lysine 63 or the N-terminus have been implicated in signaling (Dikic et
al., 2009; Hicke et al., 2005).
Protein ubiquitination is carried out by a cascade of ubiquitin-activating (E1), ubiquitin-
conjugating (E2), and ubiquitin-ligating (E3) enzymes (Deshaies and Joazeiro, 2009; Dye
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and Schulman, 2007). First, E1 forms a thioester bond between its active site cysteine and
the C-terminus of ubiquitin in an ATP-dependent manner. This charged E1 then transfers the
ubiquitin to an E2 protein, resulting in an E2~Ub thioester wherein the ubiquitin C-terminus
is attached to the catalytic cysteine residue of the E2. Subsequent binding of both E2~Ub
and substrate to an E3 enzyme enables attack of the thioester bond of E2~Ub by the ε-amino
group of a lysine residue in the substrate, leading to isopeptide bond formation. The
nucleophillic lysine can reside either within the primary sequence of the substrate, or in an
ubiquitin or ubiquitin-like protein previously conjugated to the substrate. A key point is that
for the ε-amino group of lysine to engage in a nucleophilic attack on the thioester bond, it
must be in the deprotonated (i.e. NH2) state. Given that the pKa of this group is ~10.5, the
vast majority of lysine is in the NH3+ form at physiological pH and thus must be
deprotonated as a prelude to catalysis.
The pairing of E2s and substrates by E3s determines specificity in ubiquitination. E3s are
conserved among eukaryotes, with nearly 600 E3s potentially expressed in human cells (K.
Hoffman, personal communication). There are two major types of E3s in eukaryotes,
defined by the presence of either a HECT domain or a RING or RING-like domain (Pickart,
2001). HECT domain E3s form a thioester intermediate with ubiquitin, whereas RING or
RING-like domains (hereafter referred to as RING domain for simplicity) facilitate direct
transfer of ubiquitin from the E2 to the substrate. Greater than 95 percent of E3s are of the
RING domain type, of which nearly half are cullin–RING ligases (CRLs). Befitting their
numbers, CRLs play a substantial role in protein turnover; greater than 20 percent of all
protein degradation by the 26S proteasome is blocked upon inhibition of the pan-CRL
activator, NAE (Soucy et al., 2009).
CRLs are modular multi-subunit complexes organized by a cullin scaffold. CRLs recruit E2
via a RING domain subunit, which is bound at one end of the cullin scaffold, and recruit
substrate via a receptor tethered by an adapter protein to the other end of the cullin scaffold
(Cardozo and Pagano, 2004; Deshaies and Joazeiro, 2009; Willems et al., 2004). SCF, the
prototype of the CRLs, consists of the cullin Cul1, the RING subunit Rbx1/Roc1/Hrt1, the
adaptor protein Skp1, and an F-box protein such as Skp2 or β-TrCP that binds substrates.
Recruitment of substrate and E2 to SCF and the subsequent transfer of ubiquitin have been
studied in considerable detail, making SCF the best understood ubiquitin ligase in terms of
specificity, regulation, and mechanism of action. Crystal structures for several substrate–F-
box pairs have elucidated binding of phosphorylated substrate to the F-box (Hao et al., 2005;
Orlicky et al., 2003; Wu et al., 2003). Meanwhile, the interaction between the E2 Cdc34 and
SCF has been characterized biochemically. Interaction between a basic ‘canyon’ in the Cul1
subunit and the acidic tail of Cdc34 enables rapid dynamics of Cdc34–SCF complex
formation and dissolution, which underlies rapid and processive polymerization of a K48-
linked ubiquitin chain on substrate (Kleiger et al., 2009a; Kleiger et al., 2009b). The K48
linkage specificity is dictated by the acidic loop in Cdc34, which presumably positions the
lysine 48 of the attacking ubiquitin towards the Cdc34~Ub thioester (Petroski and Deshaies,
2005).
Regarding the function of the donor ubiquitin thioesterified to E2, relatively little is known
about its role in the catalysis of protein ubiquitination, and it has been generally assumed
that the donor ubiquitin serves as a passive ‘passenger’. Currently, there are five structural
models of an E2~Ub thioester intermediate. However, in each of these models the ubiquitin
interacts differently with the E2. In the case of Ubc1, a truncated catalytic domain was used
to build an NMR-based docking model of the E2~Ub thioester (Hamilton et al., 2001). The
model predicts complementary interaction surfaces involving conserved residues in the E2
and ubiquitin proteins that could be important for catalysis. In a subsequent study, the
crystal structure of an Mms2–Ubc13~Ub complex was solved in which ubiquitin is joined to
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Ubc13 by a stable oxyester bond due to replacement of Ubc13’s catalytic cysteine with a
serine (Eddins et al., 2006). In that structure, the donor ubiquitin attached to one Mms2–
Ubc13 heterodimer is bound to the acceptor binding site of Mms 2 in an adjacent Mms2–
Ubc13 heterodimer within the crystal, and so this is not likely to reflect the normal binding
site for the donor ubiquitin. More recently, the structure of an UbcH8-Ub intermediate was
solved by NMR by replacing the thioester bond with a more stable disulphide linkage
between the C-terminal cysteine of a G76C mutant ubiquitin and the active site cysteine of
UbcH8 (Serniwka and Shaw, 2009). In this complex, the donor ubiquitin makes multiple
contacts with residues near the active site cysteine in the E2. Additionally, the crystal
structure of ubiquitin ligase Nedd4L bound to UbcH5~Ub reveals that the esterified
ubiquitin makes extensive contact with the E3 (Kamadurai et al., 2009). Finally, the crystal
structure of UbcH5b–Ub oxyester reveals that Ub esterified to one UbcH5b binds the back-
side of a second UbcH5b to form an infinite spiral (Brzovic et al., 2006; Sakata et al., 2010).
Collectively, these studies reveal that donor ubiquitin can form interactions with E2, but the
exact nature of the interaction is variable and the functional role remains poorly understood.
Here, we provide direct biochemical evidence that interaction between donor ubiquitin and
Cdc34 is critical for discharge of ubiquitin from Cdc34~Ub to substrate. A combination of
computational modeling and mutagenesis leads us to propose a model for the structure of a
discharge-competent Cdc34~Ub complex.
Results
Ubiquitin-I44A mutant is defective in substrate ubiquitination by Cdc34–SCFβ-TrCP
In the course of performing studies on the mechanism of action of Cdc34–SCF, we made the
unexpected observation that a mutant ubiquitin bearing an I44A substitution was poorly
discharged from Cdc34. This suggested to us that the ‘hydrophobic patch’ centered about
isoleucine 44, which is known to play a critical role in ubiquitin recognition by ubiquitin-
binding domains (Beal et al., 1998), might also play an important role in the transfer of
ubiquitin from E2 to substrate, possibly through interaction with the E2 to which it is
thioesterified, with the nucleophilic acceptor, or with the E3.
To better understand the molecular nature of the defect, we sought to quantify the effect of
the I44A substitution using a previously established reconstituted system to measure transfer
of ubiquitin to a 32P-labeled substrate peptide derived from β-catenin (Saha and Deshaies,
2008). In these single turnover experiments, SCF was present in stoichiometric excess of
substrate and Cdc34~Ub was saturating SCF. With wild type (WT) ubiquitin, we observed
robust ubiquitination of the peptide substrate with kcat ~ 0.3 min−1 (Figure 1A, lanes 1-6;
kcat refers to the rate of consumption of substrate, irrespective of the number of ubiquitins
transferred per molecule of substrate). By contrast, reactions carried out with ubiquitin-I44A
yielded a severe decrease in β-catenin ubiquitination with ~ 20 fold lower kcat (Figure 1A,
lanes 7-12). The decreased ubiquitination was reflected both in a lower fraction of modified
substrate and fewer ubiquitin transfers per substrate. This was not due to defect in charging
of E1 or Cdc34, since under the conditions of our assay, similar amounts of thioester were
formed with both WT ubiquitin and ubiquitin-I44A (e.g. see lanes 1 and 7 in Figures 2A and
2B). A similar discharge defect of ubiquitin-I44A was seen at 26 μM Cdc34 (not shown),
implying that it was a kcat effect and not due to a reduced KM for SCFβ-TrCP. This is further
confirmed by studies shown in Figure 2.
The activity of CRLs is regulated by covalent modification of a conserved lysine residue on
the cullin subunit with the ubiquitin-like protein, Nedd8. Nedd8 conjugation causes a major
conformational change in the ligase that substantially increases the rate at which bound
E2~Ub reacts with substrate (Duda et al., 2008; Saha and Deshaies, 2008; Yamoah et al.,
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2008). The ubiquitin-I44A mutant still showed a severe defect in substrate ubiquitination
when assayed with neddylated SCFβ-TrCP (Figure 1B).
The pattern of ubiquitin conjugates observed with ubiquitin-I44A suggested that it is
defective in both the first transfer to naïve substrate (i.e. chain initiation) as well as in
subsequent transfers to the initiator ubiquitin (i.e. chain elongation). However, the chain
elongation defect could be due to the inability of the initiator ubiquitin-I44A to serve as an
acceptor for subsequent ubiquitin transfers, because ubiquitin-I44A is a poor acceptor in
Cdc34~Ub discharge reactions (Petroski and Deshaies, 2005). To test directly whether
ubiquitin-I44A is a poor donor during chain elongation, we performed a two-stage reaction.
In the first stage, β-catenin peptide was modified with a single WT ubiquitin. This product
was then purified and used as substrate in the second-stage reaction (Saha and Deshaies,
2008). The kcat for transfer of ubiquitin-I44A to monoubiquitinated β-catenin peptide was
~25-fold slower that for WT ubiquitin (Figure 1C). Thus, the I44A mutant is not competent
to serve as a donor ubiquitin during either chain initiation or elongation. The defect observed
with ubiquitin-I44A in transfer to two very different acceptors implies that the mutation does
not perturb specific binding between the donor ubiquitin and the acceptor.
Ubiquitin-I44A is defective in discharge from Cdc34~Ub and UbcH5~Ub
To more incisively address the role of donor ubiquitin, we sought to strip down the
ubiquitination reaction to a single-turnover discharge reaction wherein ubiquitin is
transferred from Cdc34~Ub to free ubiquitin, resulting in formation of a diubiquitin
conjugate (Petroski and Deshaies, 2005). This reaction involves charging of Cdc34 with
equimolar ubiquitin in the presence of E1 and ATP, and then treating the reaction with
apyrase to remove ATP and eliminate subsequent charging. Discharge of Cdc34~Ub is then
initiated by addition of acceptor ubiquitin and formation of diubiquitin is monitored. In these
reactions, the donor ubiquitin is 32P-labeled so that both the rate of thioester discharge and
diubiquitin formation can be monitored by autoradiography.
We first examined the effect of the I44A mutation on discharge of Cdc34~Ub in the
presence of Cul1–Rbx1. Both WT ubiquitin and ubiquitin-I44A formed similar levels of
thioester intermediates under our reaction conditions (Figure 2A, compare lanes 1 and 7).
Addition of unlabeled acceptor ubiquitin in the presence of Cul1–Rbx1 resulted in rapid
discharge of the thioester to form diubiquitin. Both the rate of thioester discharge as well as
the rate of product formation was ≥5 fold faster with WT ubiquitin compared to the I44A
mutant (Figure 2A). This is a minimum estimate, because the initial rate of SCF-catalyzed
discharge of WT ubiquitin was too rapid to be accurately measured under these conditions.
We next addressed whether the I44A mutation compromises interaction of donor ubiquitin
with Cdc34 or with SCF by further simplifying the discharge reaction to measure SCF-
independent discharge of the Cdc34~Ub thioester to free ubiquitin. In this experiment,
reactants and products were monitored by staining with Coomassie Blue, followed by
quantification by autoradiography. As for the previous experiments, ubiquitin-I44A thioester
was severely compromised in its ability to discharge, resulting in diminished diubiquitin
product formation (Figure 2B). To quantify the defect in the discharge rate we measured the
difference in the rate of single exponential decay of the thioester. This provides a more
accurate estimate of the discharge rate because it is independent of the starting amount of the
thioester. This revealed that ubiquitin-I44A was discharged to acceptor ubiquitin ~ 9 fold
more slowly than WT ubiquitin. Thus, the donor ubiquitin plays a critical role in discharge
that is independent of SCF. We conclude that association of the hydrophobic patch of the
donor ubiquitin with the surface of Cdc34 plays an important role in ubiquitin discharge.
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Interestingly, in the modeled structure of Ubc1~Ub thioester, I44 is amongst the residues
that are at the interface with Ubc1 (Hamilton et al., 2001). Therefore, we next sought to test
whether the role of ubiquitin’s hydrophobic patch in discharge is unique to Cdc34~Ub, or if
this is a more general phenomenon that applies to other E2s. To address this question, we
performed β-catenin peptide ubiquitination assays with UbcH5c–SCFβ-TrCP. Similar to
Cdc34, we observed that ubiquitin-I44A exhibited a ≥20 fold defect in substrate
ubiquitination by UbcH5c (Figure 2C).
Charge swap in Cdc34 rescues thioester discharge defect of R42E ubiquitin
If the discharge defect of ubiquitin-I44A is due to loss of interaction with the E2 to which it
is charged, it should be possible to identify compensatory mutations on the surface of the E2
that restore proper interaction and suppress the discharge defect. To gain further insight into
the interface between the thioesterified donor ubiquitin and Cdc34, we used the modeled
Ubc1~Ub thioester structure as a guide (Hamilton et al., 2001). In this model, I44 is adjacent
to the α3 helix of Ubc1 (Figure S1). Another residue at the E2~Ub interface is arginine 42 of
ubiquitin. Based on this model we introduced a charge-swap mutation in ubiquitin, R42E,
that could potentially disrupt the interaction with Cdc34. To ensure that we were monitoring
exclusively effects on E2-ubiquitin interaction, we performed discharge reactions in the
absence of SCF. We found that ubiquitin-R42E was charged onto Cdc34 by E1 enzyme, but
was compromised in both discharge from Cdc34 and diubiquitin formation (Figure 3A, lanes
1-6 compared to Figure 2B, lanes 1-6). Quantification based on single exponential decay of
the thioester indicated that the ubiquitin-R42E thioester was ~ 4 fold defective in discharge.
Defects of similar magnitude were observed when ubiquitin-R42E discharge to free
ubiquitin (Figure 3B) or β-catenin peptide (Figure 3C) were measured in the presence of
Cul1–Rbx1 or SCFβ-TrCP, respectively.
To identify residues in Cdc34 that might counteract the effect of the R42E substitution in
ubiquitin, we superimposed the sequence of Cdc34 on the Ubc1~Ub structure model. This
implicated glutamate 133 of Cdc34 as being a potential interacting partner with residue 42
of ubiquitin. To evaluate this possibility, we generated and assayed a Cdc34-E133R mutant.
The E133R mutation by itself had little effect on Cdc34 activity (Figure S2). Strikingly,
however, Cdc34-E133R almost completely rescued the SCF-independent thioester discharge
defect of ubiquitin-R42E. The rate of discharge of ubiquitin-R42E from Cdc34-E133R
(0.071 min−1; Figure 3A, lanes 7-12) was nearly the same as the rate of discharge of WT
ubiquitin from WT Cdc34 (0.079 min−1; Figure 2B). We also observed suppression of the
discharge defect of ubiquitin-R42E by Cdc34-E133R when ubiquitin discharge/diubiquitin
synthesis assays were carried out in the presence of Cul1–Rbx1 (Figure 3B) or when
ubiquitination of β-catenin peptide was assayed in the presence of SCFβ-TrCP (Figure 3C). It
is worth noting that if R42 of ubiquitin makes multiple contacts with Cdc34 besides E133
(but not vice versa), then the E133R mutation by itself would not necessarily inactivate
Cdc34. The rescue of the ubiquitin-R42E mutant by a complementary charge swap in Cdc34
argues strongly that productive interaction between the donor ubiquitin and Cdc34 is critical
for efficient discharge of the thioester.
Rescue of ubiquitin-I44A defect by compensatory mutation in Cdc34 predicted from a
docked thioester model
To further explore the interface between Cdc34 and thioesterified ubiquitin and seek deeper
support for our hypothesis, we created a docking model from Cdc34 (2OB4) and ubiquitin
(1UBQ) using a custom protocol written in Rosetta3 (Das and Baker, 2008; Leaver-Fay et
al., 2011). Besides the thioester bond between the C-terminus of ubiquitin and Cdc34’s
catalytic cysteine, the following two constraints were satisfied: (1) one of the charged atoms
on the side chain of R42 of ubiquitin must be in close proximity with the charged atom on
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the side chain of E133 of Cdc34, and (2) I44 of ubiquitin must be close enough to at least
one side chain on the surface of Cdc34 to engage in a van der Waals interaction. Whereas
models lacking constraints predicted a wide variety of low energy structures (Figure S3), the
imposition of these constraints enabled generation of a docked structure that allowed us to
predict that serine 129 of Cdc34 is in close proximity to I44 of ubiquitin (Figure 4).
Based on the docking model, we predicted that an S129L mutation in Cdc34 should cause
steric clash with I44 of ubiquitin due to the larger side chain of leucine relative to serine,
rendering Cdc34-S129L defective in thioester discharge. To test this prediction we measured
the rate of thioester discharge of Cdc34-S129L~Ub thioester in an SCF-independent
diubiquitin synthesis assay and found it to be ~3.5-fold defective compared to WT Cdc34
(Figure 5A, lanes 1-6 compared to Figure 2B, lanes 1-6). Likewise, Cdc34-S129L was also
defective in sustaining SCFβ-TrCP-dependent ubiquitination of β-catenin peptide (Figure 5B,
lanes 1-6 compared to lanes 13-18). Based on our docking model, the defect in discharge of
ubiquitin from Cdc34-S129L~Ub should be compensated by relieving the steric clash by
placing a smaller side chain at position 44 of ubiquitin. We therefore reasoned that the I44A
mutant, which by itself was profoundly defective in discharge, should relieve the steric clash
and restore normal activity to Cdc34-S129L. Remarkably, ubiquitin-I44A and Cdc34-S129L
rescued each other quite strongly: ubiquitin-I44A was discharged from Cdc34-S129L at a
rate (0.064 min−1; measured as a single exponential decay) that was 80% the rate of
discharge of WT ubiquitin from WT Cdc34 (0.079 min−1). Ubiquitin-I44A did not
efficiently form a thioester with Cdc34-S129L (Figure 5A and Figure S4), but that did not
interfere with our measurement because the rate of discharge was estimated based on a
single exponential decay of the input thioester. Cdc34-S129L was also tested in an
SCFβ-TrCP-dependent β-catenin peptide ubiquitination assay with ubiquitin-I44A (Figure
5B, lanes 19-24). Although ubiquitin-I44A failed to improve the activity of Cdc34-S129L,
Cdc34-S129L rescued the defect of ubiquitin-I44A. The failure of ubiquitin-I44A to rescue
Cdc34-S129L in a multi-turnover reaction was most likely due to the low efficiency of
thioester formation, which is not a problem in a single-turnover chase experiment such as
the one in Figure 5A. Taken together, these experiments indicate that serine 129 of Cdc34
packs against the I44 residue of Ub and this interaction is important for efficient thioester
discharge.
Cdc34 interaction with donor ubiquitin facilitates specific steps in catalysis of isopeptide
bond formation
To gain insight into the biochemical basis of the ubiquitin-I44A defect, we employed an
assay that monitors discharge of ubiquitin to the freely diffusing nucleophile hydroxylamine
(Saha and Deshaies, 2008). Unexpectedly, in contrast to all of the other assays presented
above, ubiquitin-I44A was discharged to hydroxylamine with normal kinetics (Figure 6A).
Hydroxylamine differs from the other acceptors employed in this study in that it has a lower
molecular weight and the pKa of the primary amine is far lower (6.0 vs. 10.5 for the ε-amino
group of lysine). The low pKa of hydroxylamine should reduce dependence on catalytic
elements that mediate deprotonation of the attacking lysine. To determine whether the low
pKa of hydroxylamine might account, at least in part, for the suppression of the I44A
mutation, we performed diubiquitin synthesis assays at pH 7.0 and 9.2. The idea behind this
experiment is that the fraction of lysine that is protonated is ~100-fold less at pH 9.2
compared to pH 7, therefore a ubiquitination reaction carried out at the high pH should be
less dependent on catalytic elements that mediate lysine deprotonation. To eliminate
confounding effects on ubiquitin activation, this experiment was carried out under single-
turnover discharge conditions similar to Figure 2B. Reactions carried out at higher pH
narrowed the gap between reaction rates measured for WT and I44A ubiquitin (Figures 6B,
C). The rate of diubiquitin synthesis with wild type donor was 12-fold faster than mutant at
Saha et al. Page 6
Mol Cell. Author manuscript; available in PMC 2012 April 8.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
pH 7 but only 5-fold faster at pH 9.2 (Figure 6C, S5). Meanwhile, discharge of WT
ubiquitin from Cdc34 was 6-fold faster than I44A at pH 7 and only 2-fold faster at pH 9.2.
The better activity of I44A in the discharge reaction at higher pH was partly attributable to a
higher fraction of the mutant thioester being hydrolyzed to regenerate free ubiquitin, at the
expense of forming diubiquitin.
Discussion
Models of ubiquitination have typically assumed that the donor ubiquitin thioesterified to
the E2 enzyme is a passive participant in the transfer reaction. We provide strong evidence
that the isoleucine 44 residue of ubiquitin, which has been implicated in interactions with
numerous ubiquitin-binding proteins, is also critical for transfer of donor ubiquitin from
Cdc34~Ub thioester to substrate. Isoleucine 44 on the donor ubiquitin is important for
transfer at both the initiation and elongation steps of ubiquitin chain assembly upon SCF
substrates. Isoleucine 44 is also important for discharge of ubiquitin from Cdc34~Ub to free
ubiquitin in the presence or absence of SCF. Finally, I44 is also important for transfer of
ubiquitin from UbcH5~Ub to substrate.
The simplest model to explain our results is that the ubiquitin thioesterified to an E2 engages
in interactions with the surface of the E2 that favor attack of the thioester bond by a
nucleophilic acceptor. This hypothesis is consistent with structural models of Ubc1~Ub and
UbcH8~Ub complexes that have been developed based on NMR data (Hamilton et al., 2001;
Serniwka and Shaw, 2009). In each case, the thioesterified ubiquitin engages in interactions
with surface residues on the E2, but the functional significance of these interactions was not
explicitly demonstrated.
To probe the interaction between Cdc34 and its thioesterified ubiquitin cargo, we pursued
two lines of experimentation. In the first test, we used homology modeling based on the
Ubc1~Ub structure to generate charge-swap mutations in residues of Cdc34 (E133) and
ubiquitin (R42) that were predicted to be in close proximity. In agreement with the
homology model, an R42E mutation interferes with discharge of ubiquitin from wild type
Cdc34, but this mutation is efficiently suppressed by compensatory introduction of an
E133R mutation in Cdc34. Remarkably, when assayed in combination the two mutants
exhibited nearly as much activity as was observed in reactions with wild type components.
In the second test of our hypothesis, we used the information gathered in the first experiment
as a constraint to model a Cdc34~Ub complex using Rosetta3 (Leaver-Fay et al., 2011). This
model led to the prediction that an S129L mutation in Cdc34 should generate a steric clash
with I44 of ubiquitin. Indeed, Cdc34-S129L showed reduced activity when assayed with
wild type ubiquitin, but the Cdc34-S129L and ubiquitin-I44A mutations mutually
suppressed each other. The simplest interpretation of our results is that the hydrophobic
patch of ubiquitin comprising I44 binds in the vicinity of S129 on the surface of the Cdc34
to which it is thioesterified.
How does interaction between ubiquitin and the E2 to which it is thioesterified enhance its
discharge? Formation of an isopeptide bond involves attack of a nucleophile at the thioester
linkage to form an oxyanion transition state, which then resolves to yield product. Given that
the pKa of the ε-amino group of lysine is ~10.5, at physiological pH the vast majority of
lysine side chains are protonated (NH3+) and thus incompetent to engage in nucleophilic
attack. With the exception of Ubc9 (Yunus and Lima, 2006), the mechanism underlying
nucleophilic activation of lysine is poorly understood. We found that either using a low pKa
acceptor (hydroxylamine; pKa ~6.0) or conducting reactions at pH 9.2 considerably
improved the ability of ubiquitin–I44A to serve as a donor, suggesting that
Cdc34~ubiquitin–I44A complexes are deficient in nucleophilic activation. Presumably,
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docking of donor ubiquitin to Cdc34 influences the positioning of S138, which has been
proposed to play a critical role in nucleophilic activation (Yunus and Lima, 2006).
Interestingly, the ubiquitin–I44A thioester exhibited appreciable hydrolysis in single-
turnover diubiquitin synthesis assays. We suggest that interaction between the donor
ubiquitin and Cdc34 helps to organize the active site to favor efficient formation of
isopeptide bonds at the expense of other side reactions such as hydrolysis. A deeper
mechanistic understanding of how ubiquitin-Cdc34 interaction organizes the active site to
facilitate nucleophilic activation and isopeptide bond formation awaits the crystal structure
of an intermediate in the transfer process.
Results in other systems support the concept that an active role for the donor ubiquitin in the
transfer process is a conserved feature of ubiquitination pathways. As noted above, the
NMR-based structural models for Ubc1~Ub and UbcH8~Ub point to a cis interaction
between the proteins. In addition, the crystal structure of an UbcH5b~Ub complex with the
HECT domain E3 Nedd4L revealed that the thioesterified ubiquitin engages in interactions
with Nedd4L (Kamadurai et al., 2009). Finally, while the revised version of this manuscript
was under review, (Wickliffe et al., 2011) reported that association of donor ubiquitin with
Ube2S is important for its transfer to substrate. Using NMR chemical shift data, these
authors derived a computational model for the structure of Ube2S~Ub. The authors used this
model as a guide to generate mutations in Cdc34 (T122E, L125A, I128E) that disrupted the
discharge of donor ubiquitin. These mutations map to the same helix as the S129L
substitution described in this work (Figure S7), suggesting that the donor ubiquitin–E2
interaction described here is a conserved feature of E2 function. We propose that interaction
of the hydrophobic patch of ubiquitin with the surface of E2 can serve at least two different
purposes in addition to promoting ubiquitin discharge. First, it helps to maintain ubiquitin-
like protein (UBL) specificity by requiring an interaction between UBL and ubiquitination
enzyme at multiple steps in the transfer cascade. Second, it shields the hydrophobic patch
from interacting with the many proteins in eukaryotic cells that recognize this surface. These
results have important implications for attempts to reengineer or modulate the activity of
ubiquitination pathways with mutants or small molecules.
Experimental procedures
Expression and purification of recombinant proteins
All proteins were recombinantly expressed in either E. coli or Hi5 insect cells and purified
using standard procedures as outlined in Table S1.
Ubiquitination assay
All β-catenin substrate ubiquitination reactions (20 μl) were performed as described
previously at 23°C in a buffer containing 30 mM Tris-Cl (pH 7.3), 100 mM NaCl, 5 mM
MgCl2, 2 mM ATP, 2 mM DTT and typically contained 1 μM E1, 10 μM E2, E3 (as
indicated), and 30 μM ubiquitin (Saha and Deshaies, 2008). Reactions were initiated by
mixing E2~Ub to the preformed E3–Substrate complex. All reactions were quenched in
reducing SDS sample buffer, resolved by SDS-PAGE, phosphor imaged, and quantified
using Image Quant (G. E. Healthcare).
Diubiquitin synthesis reactions (20 μl) were performed as described previously at 23°C in a
buffer containing 30 mM Tris-Cl (pH 7.3), 100 mM NaCl, 5 mM MgCl2, 2 mM ATP, 2 mM
DTT (Saha and Deshaies, 2008). Typically 10 μM Cdc34 was pre-incubated with
equimolar 32P-labeled ubiquitin in the presence of 1 μM E1 and ATP for 10 min at 23°C,
followed by 5 min incubation with 2U apyrase (Sigma). Discharge of Cdc34~Ub was
initiated by adding 120 μM ubiquitin-D77 (E3-independent) or 75 μM ubiquitin-D77 (Cul1–
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Rbx1 dependent, 300 nM). The addition of aspartate 77 following glycine 76 of ubiquitin
ensures that it can only act as an acceptor ubiquitin in a steady-state diubiquitin synthesis
assays (Petroski and Deshaies, 2005). For reactions in Figure 6 at pH 7.0 and 9.2, charging
was done in a buffer containing 200 μM ATP, in the presence of 2.5 μM E1 and 15 mM 32P-
labeled ubiquitin. Charging reactions were quenched by incubating with 2U apyrase for 5
min, followed by addition of 5 mM EDTA (final) (Figure S6). 5 μl of the thioester reaction
was diluted in 20 μl of chase buffer with 50 mM bis-Tris-propane and 240 μM ubiquitin-
D77 (final). Aliquots were removed at the indicated times and quenched with non-reducing
sample buffer supplemented with 5 mM NEM. Samples were resolved by SDS-PAGE,
analyzed by autoradiography and quantified using Image Quant (G. E. Healthcare). Rates of
thioester discharge was fitted to a single exponential decay (y = (m1-m3)*exp(−m2*m0) +
m3) using KaleidaGraph software. Rates were estimated for each replicates and averaged.
All values reported are the average of at least two independent experiments.
Rosetta docking model
To model the Cdc34–ubiquitin interaction, a protocol was written as a part of the Rosetta3
suite (Leaver-Fay et al., 2011). It was designed to search the conformational space available
to ubiquitin chemically conjugated via thioester to Cdc34 by sampling rotation about torsion
angles near the thioester bond. For input structure, ubiquitin (1UBQ) and Cdc34 (2OB4)
were used. To bias sampling towards conformations relevant to the experimental data,
constraints were introduced and the top 20 hits based on the score was analyzed, which
strongly suggested interaction between ubiquitin I44 and Cdc34 S129. Detailed procedure is
outlined in the supplemental section.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Ubiquitin-I44A cannot serve as a donor for ubiquitin chain initiation or elongation catalyzed
by Cdc34–SCFβ-TrCP complex
(A) 32P-labeled β-catenin peptide (β-cat; 100 nM) was incubated with WT ubiquitin (lanes
1-6) or ubiquitin-I44A (lanes (7-12) in the presence of E1, ATP, 10 μM Cdc34 and 300 nM
SCFβ-TrCP. Aliquots were removed at the indicated times and analyzed for substrate
ubiquitination (Ubn β-cat) by SDS-PAGE followed by autoradiography.
(B) Same as in (A) but using 300 nM neddylated SCFβ-TrCP complex.
(C) Same as in (A) but using 32P-labeled monoubiquitinated β-catenin peptide substrate
(Ub-β-cat; 1.5 μM) and 300 nM SCFβ-TrCP.
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Figure 2.
The discharge defect of ubiquitin-I44A is intrinsic to the E2~Ub-I44A thioester complex.
(A) Cdc34 (10 μM) was pre-incubated with equimolar 32P-labeled WT ubiquitin (lanes 1-6)
or ubiquitin-I44A (lanes 7-12) in the presence of 1 μM E1 and ATP for 10 min at 23°C,
followed by 5 min incubation with apyrase to terminate charging. Discharge of Cdc34~Ub
was initiated by adding 75 μM ubiquitin-D77 plus 300 nM Cul1–Rbx1 and aliquots were
removed at the indicated times and quenched with non-reducing sample buffer, resolved by
SDS-PAGE, and analyzed by autoradiography. Rate of diubiquitin synthesis was estimated
per unit Cul1–Rbx1. * denotes triubiquitin product.
(B) Same as in (A), except no Cul1–Rbx1 was added. Also, 120 μM ubiquitin-D77 was
used, and the gel was stained with coomassie blue to reveal amounts of charged and
discharged Cdc34. A Phosphor image of the stained gel was quantified and plotted, from
which the rate of Cdc34~Ub discharge was estimated by fitting to a single exponential decay
(right panel). A representative experiment is shown and the values reported (mean ± SD) are
an average of 3 independent experiments.
(C) 32P-labeled β-catenin peptide (2 μM) was incubated with WT ubiquitin (lanes 2-5) or
ubiquitin-I44A (lanes 6-9) in the presence of E1, ATP, 10 μM UbcH5c and 200 nM
SCFβ-TrCP. Aliquots were removed at the indicated times and analyzed by SDS-PAGE
followed by autoradiography.
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Figure 3.
E133R mutation in Cdc34 rescues thioester discharge defect of ubiquitin-R42E.
(A) 10 μM WT Cdc34 (lanes 1-6) or E133R mutant (lanes 7-12) was pre-incubated with
equimolar 32P-labeled R42E Ub in the presence of 1 μM E1 and ATP for 10 min at 23°C,
followed by 5 min incubation with apyrase. Discharge of Cdc34~Ub was initiated by adding
120 μM ubiquitin-D77 and aliquots were removed at the indicated times, quenched,
fractionated by SDS-PAGE, and analyzed by coomassie blue staining followed by
autoradiography. The image shown is that of the stained gel, and the phosphor image was
quantified and plotted. The rate of Cdc34~Ub discharge was estimated by fitting to a single
exponential decay (right panel). Shown is a representative experiment and the values
reported (mean ± SD) are the average of 2 independent experiments.
(B) Same as in (A), but with the addition of 300 nM Cul1–Rbx1 complex and 75 μM
ubiquitin-D77 (autorad image shown). * denotes triubiquitin product.
(C) 32P-labeled β-catenin peptide (1.5 μM) was ubiquitinated using WT Cdc34 (lanes 1-6)
or Cdc34-E133R (lanes 7-12) in the presence of E1, ATP, 30 μM ubiquitin-R42E and 300
nM SCFβ-TrCP. Aliquots were removed at the indicated times and substrate ubiquitination
analyzed by SDS-PAGE followed by autoradiography. * denotes contaminating band from
the substrate.
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Figure 4.
Serine 129 of Cdc34 is in close proximity to isoleucine 44 of ubiquitin in a constrained
Cdc34~Ub model.
Rosetta docking model for Cdc34~Ub thioester was generated by constraining the position
of R42 of ubiquitin to be in close proximity to E133 of Cdc34. The thioester bond as well as
the key residues for interaction are indicated. The figure was made in PYMOL.
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Figure 5.
S129L mutation in Cdc34 suppresses the defect in thioester discharge of ubiquitin-I44A.
(A) Cdc34-S129L (10 μM) was pre-incubated with equimolar 32P-labeled WT ubiquitin
(lanes 1-6) or ubiquitin-I44A (lanes 7-12) in the presence of 1 μM E1 and ATP for 10 min at
23°C, followed by 5 min incubation with apyrase. Discharge of Cdc34~Ub was initiated by
adding 120 μM ubiquitin-D77 and aliquots were removed at the indicated times and
quenched and analyzed by SDS-PAGE followed by autoradiography. The rate of Cdc34~Ub
discharge was estimated by fitting to a single exponential decay. Shown is a representative
experiment and the values reported (mean ± SD) are average of 2 independent experiments.
* denotes triubiquitin product.
(B) 32P-labeled β-catenin peptide (100 nM) was incubated with WT Cdc34 (lanes 1-12) or
the S129L mutant (lanes 13-24) in the presence of E1, ATP, 300 nM SCFβ-TrCP, and 30 μM
WT ubiquitin (lanes 1-6 and 13-18) or ubiquitin-I44A (lanes 7-12 and 19-24). Aliquots were
removed at the indicated times and substrate ubiquitination was analyzed by SDS-PAGE
followed by autoradiography.
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Figure 6.
Cdc34~I44A–ubiquitin complex is defective in nucleophilic activation
(A) Cdc34 (10 μM) was pre-incubated with equimolar 32P-labeled WT ubiquitin (lanes 1-6)
or ubiquitin-I44A (lanes 7-12) in the presence of 1 μM E1 and ATP for 10 min at 23°C,
followed by 5 min incubation with apyrase. Discharge of Cdc34~Ub was initiated by adding
4 mM hydroxylamine and aliquots were removed at the indicated times and quenched with
non-reducing sample buffer. Rate of Cdc34~Ub discharge to form Ub-NHOH (which has
been verified by mass spectrometry; Saha and Deshaies, 2008) was estimated and reported
(mean ± SD).
(B) The rate of donor ubiquitin discharge to ubiquitin-D77 acceptor was measured for
Cdc34 (6 μM) thioesterified with WT ubiquitin (lanes 1-12) or I44A ubiquitin (lanes 13-24).
Discharge rates were measured at pH 7.0 (lanes 1-6 and 13-18) and pH 9.2 (lanes 7-12 and
19-24). Quantification of the gel is shown in Figure S5. *For unknown reasons,
thioesterified Cdc34 resolved as two bands in this set of experiments.
(C) Estimates of reaction rates from Figure 6B.
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